Tacere Therapeutics, Inc.
H‑1B Sponsor Verified
Yes. Tacere Therapeutics, Inc. filed 8 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2020–2026, including 2 so far in 2026. The average H-1B salary is $180,847 and the most sponsored role is Chief Financial Officer.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: Apr 9, 2026.
LinkedIn ↗Latest Year Filings
2
In 2026
↗ Filter by year
Total H‑1B Filings
8
Since 2020
↗ View records
Avg Annual Salary
$180,847
All years combined
↗ View chart
Top Role
Chief Financial Officer
↗ Click to filter
Filing trend
H‑1B filings by year for Tacere Therapeutics, Inc.
| Year | LCA filings | Avg salary |
|---|---|---|
| 2026 | 2 | $168,990 |
| 2025 | 2 | $333,450 |
| 2024 | 1 | $112,422 |
| 2023 | 1 | $140,595 |
| 2021 | 1 | $90,000 |
| 2020 | 1 | $98,880 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary